Tremfya on Wellcare Value Script (S4802-158)
guselkumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 2 per 28 days.
$3,484.23
Patient pays / month, after deductible
$3,945.48
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
TREMFYA 200 mg/2mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $13,936.91 for a month. Other covered strengths are listed below.
Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| TREMFYA 100 mg/mL Injection | 5 | $7,042.08 | PA · 2 per 28 days |
| TREMFYA 100 mg/mL Injection | 5 | $7,077.50 | PA · 2 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $3,484.23 | PA · 2 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $3,655.09 | PA · 12 per 180 days |
| TREMFYA 200 mg/2mL Injection | 5 | $3,655.09 | PA · 2 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (888)550-5252. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s4802-158